Phage-encoded depolymerases as a strategy for combating multidrug-resistant Acinetobacter baumannii
Frontiers in Cellular and Infection Microbiology · 2024
DOI: 10.3389/fcimb.2024.1462620 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Md Minarul Islam und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, College of Science and Technology, Dankook University, Cheonan, Republic of Korea. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Bacteriophages, Drug Resistance, Multiple, Bacterial, Acinetobacter Infections. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Acinetobacter baumannii , a predominant nosocomial pathogen, represents a grave threat to public health due to its multiple antimicrobial resistance. Managing patients afflicted with severe infections caused by multiple drug-resistant A. baumannii is particularly challenging, given the associated high mortality rates and unfavorable prognoses. The diminishing efficacy of antibiotics against this superbug underscores the urgent necessity for novel treatments or strategies to address this formidable issue. Bacteriophage-derived polysaccharide depolymerase enzymes present a potential approach to combating this pathogen. These enzymes target and degrade the bacterial cell’s exopolysaccharide, capsular polysaccharide, and lipopolysaccharide, thereby disrupting biofilm formation and impairing the bacteria’s defense mechanisms. Nonetheless, the narrow host range of phage depolymerases limits their therapeutic efficacy. Despite the benefits of these enzymes, phage-resistant strains have been identified, highlighting the complexity of phage-host interactions and the need for further investigation. While preliminary findings are encouraging, current investigations are limited, and clinical trials are imperative to advance this treatment approach for broader clinical applications. This review explores the potential of phage-derived depolymerase enzymes against A. baumannii infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, College of Science and Technology, Dankook University, Cheonan, Republic of Korea.
- Smart Animal Bio Institute, Dankook University, Cheonan, Republic of Korea.
- Department of Biomedical Sciences and Institute for Medical Science, Jeonbuk National University Medical School, Jeonju, Republic of Korea.
- Department of Pharmaceutical Sciences, Northeast Ohio Medical University, Rootstown, OH, United States.
- Center for Bio-Medical Engineering Core Facility, Dankook University, Cheonan, Republic of Korea.
Zitieren
APA
Islam, M. M., Mahbub, N. U., Shin, W. S., & Oh, M. H. (2024). Phage-encoded depolymerases as a strategy for combating multidrug-resistant Acinetobacter baumannii. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1462620
Vancouver
Islam MM, Mahbub NU, Shin WS, Oh MH. Phage-encoded depolymerases as a strategy for combating multidrug-resistant Acinetobacter baumannii. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1462620
BibTeX
@article{Islam2024,
author = {Islam, Md Minarul and Mahbub, Nasir Uddin and Shin, Woo Shik and Oh, Man Hwan},
title = {Phage-encoded depolymerases as a strategy for combating multidrug-resistant Acinetobacter baumannii},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
doi = {10.3389/fcimb.2024.1462620}
}
EUVIMED